文献速递甲状腺疾病

八种自身免疫性疾病与甲状腺癌的关联:一项全国性队列研究

Association Between Eight Autoimmune Diseases and Thyroid Cancer: A Nationwide Cohort Study.
PubMed 文献 · Thyroid · 2024-01-23

该全国性回顾性匹配队列研究利用国民健康保险服务-全国样本队列,比较八种自身免疫性疾病患者与无自身免疫性疾病对照者的甲状腺癌发病风险。平均随访9.49年,对照组新发甲状腺癌138例,八种自身免疫性疾病组共268例。桥本甲状腺炎、Graves病、炎症性肠病、白癜风、类风湿关节炎及八种自身免疫性疾病总体均与甲状腺癌风险升高相关。

要点

  • 桥本甲状腺炎(HR=2.10)、Graves病(HR=2.67)、炎症性肠病(HR=2.06)、白癜风(HR=1.71)、类风湿关节炎(HR=1.76)患者甲状腺癌风险升高。
  • 八种自身免疫性疾病总体甲状腺癌风险升高(HR=1.97 [1.60-2.42])。
  • 甲状腺特异性自身免疫性疾病与甲状腺癌的关联最强(HR=2.37 [1.85-3.03])。

核心结论

  • 特定自身免疫性疾病,尤其是甲状腺特异性自身免疫性疾病、白癜风、炎症性肠病和类风湿关节炎,与甲状腺癌风险升高相关。

研究设计与样本

  • 全国性回顾性匹配队列研究,使用国民健康保险服务-全国样本队列,比较八种自身免疫性疾病患者与无自身免疫性疾病对照者的甲状腺癌发病风险。
  • 采用Cox比例风险模型估计各自身免疫性疾病相对于无自身免疫性疾病对照组的甲状腺癌调整风险比(HR)及置信区间(CI)。

主要发现

  • 平均随访9.49年期间,对照组新发甲状腺癌138例,八种自身免疫性疾病组发生268例。
  • 与无自身免疫性疾病对照组相比,桥本甲状腺炎患者甲状腺癌风险升高(HR=2.10 [1.57-2.81]),Graves病患者升高(HR=2.67 [1.99-3.62]),炎症性肠病患者升高(HR=2.06 [1.50-2.83]),白癜风患者升高(HR=1.71 [1.13-2.59]),类风湿关节炎患者升高(HR=1.76 [1.07-2.90]),八种自身免疫性疾病总体升高(HR=1.97 [1.60-2.42])。
  • 将自身免疫性疾病分为三型后,甲状腺特异性自身免疫性疾病与甲状腺癌的关联最强且显著(HR=2.37 [1.85-3.03]),其次为局部自身免疫性疾病(HR=1.83 [1.41-2.38]),系统性自身免疫性疾病(HR=1.77 [1.14-2.74])。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: It has often been reported that thyroid-specific autoimmune diseases (ADs), such as Hashimoto's thyroiditis and Graves' disease, could increase the risk of thyroid cancer, but the association between other ADs beyond thyroid and thyroid cancer has not been well investigated. This study aimed to examine the risk of thyroid cancer in patients with eight ADs compared with those without ADs. Methods: This nationwide retrospective matched cohort study was conducted to investigate the relationship of eight ADs (Hashimoto's thyroiditis, Graves' disease, type 1 diabetes mellitus, Sjogren's disease, inflammatory bowel disease [IBD], vitiligo, systemic lupus erythematosus, and rheumatoid arthritis [RA]) with the risk of incident thyroid cancer using the National Health Insurance Service-National Sample Cohort. The Cox-proportional hazard model was used to estimate the adjusted hazard ratio (HR) and confidence intervals (CI) for thyroid cancer in relation to each of AD compared with control group without AD. Results: During the average follow-up of 9.49 years, 138 thyroid cancer cases were newly developed in control group and 268 cases were occurred in group with 8 ADs. For all of study participants, the risk of thyroid cancer was significantly increased in patients with Hashimoto's thyroiditis (HR = 2.10 [1.57-2.81]), Graves' disease (HR = 2.67 [1.99-3.62]), IBD (HR = 2.06 [1.50-2.83]), vitiligo (HR = 1.71 [1.13-2.59]), RA (HR = 1.76 [1.07-2.90]), and total of 8 ADs (HR = 1.97 [1.60-2.42]) compared with control group without ADs. When ADs were divided into three types, thyroid-specific ADs (HR = 2.37 [1.85-3.03]) showed the strongest and significant association with thyroid cancer, followed by local ADs (HR = 1.83 [1.41-2.38]), and systemic ADs (HR = 1.77 [1.14-2.74]). Conclusions: Specific ADs-especially for thyroid-specific AD, vitiligo, IBD, and RA-were associated with increased risk for thyroid cancer.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Park SK, Ryoo JH, Kim MH, et al. Association Between Eight Autoimmune Diseases and Thyroid Cancer: A Nationwide Cohort Study. Thyroid. 2024. PMID: 38149584. doi:10.1089/thy.2023.0353

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。